Endothelin-converting enzyme-1 (ECE-1) is post-transcriptionally regulated by alternative polyadenylation
about
EndothelinNeuropeptide substance P and the immune response.Cleavage and polyadenylation: Ending the message expands gene regulation.Pharmacological hypothesis: Nitric oxide-induced inhibition of ADAM-17 activity as well as vesicle release can in turn prevent the production of soluble endothelin-converting enzyme.A tRNA fragment, tRF5-Glu, regulates BCAR3 expression and proliferation in ovarian cancer cells.
P2860
Endothelin-converting enzyme-1 (ECE-1) is post-transcriptionally regulated by alternative polyadenylation
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 31 January 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Endothelin-converting enzyme-1 ...... by alternative polyadenylation
@en
Endothelin-converting enzyme-1
@nl
type
label
Endothelin-converting enzyme-1 ...... by alternative polyadenylation
@en
Endothelin-converting enzyme-1
@nl
prefLabel
Endothelin-converting enzyme-1 ...... by alternative polyadenylation
@en
Endothelin-converting enzyme-1
@nl
P2093
P2860
P1433
P1476
Endothelin-converting enzyme-1 ...... by alternative polyadenylation
@en
P2093
Alison R Whyteside
Anthony J Turner
Daniel W Lambert
P2860
P304
P356
10.1371/JOURNAL.PONE.0083260
P407
P577
2014-01-31T00:00:00Z